Pauline Rudd

Pauline Rudd's AcademicInfluence.com Rankings

Pauline Rudd

Biology

#8950

World Rank

#12097

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Pauline Rudd Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Pauline Rudd is a British biochemist and Professor at the Microbiome Institute, University College Cork. She is a founder of Wessex Biochemicals, a Fellow of the Royal Society of Medicine and was awarded the James Gregory Medal in 2010.

(See a Problem?)

Pauline Rudd's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Glycosylation and the immune system. (2001) (1386)
The impact of glycosylation on the biological function and structure of human immunoglobulins. (2007) (1185)
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9) (2002) (848)
Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein (1995) (751)
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition (2003) (745)
The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 (2002) (700)
Concepts and principles of O-linked glycosylation. (1998) (697)
A systematic approach to protein glycosylation analysis: a path through the maze. (2010) (580)
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity (2001) (519)
A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. (1996) (459)
Glycans as cancer biomarkers. (2012) (427)
HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. (2008) (424)
The Mannose Receptor Mediates Dengue Virus Infection of Macrophages (2008) (420)
Glycosylation: heterogeneity and the 3D structure of proteins. (1997) (407)
High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations* (2011) (400)
The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor Interactions* (1998) (394)
Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. (2007) (365)
Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. (2007) (359)
Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers (2013) (307)
Secretory IgA N- and O-Glycans Provide a Link between the Innate and Adaptive Immune Systems* (2003) (305)
Evaluation of the serum N‐linked glycome for the diagnosis of cancer and chronic inflammation (2008) (287)
Glycoforms modify the dynamic stability and functional activity of an enzyme. (1994) (283)
GlycoBase and autoGU: tools for HPLC-based glycan analysis (2008) (274)
Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. (2003) (273)
Glycosylation differences between the normal and pathogenic prion protein isoforms. (1999) (265)
Proposal for a standard system for drawing structural diagrams of N‐ and O‐linked carbohydrates and related compounds (2009) (246)
Function and glycosylation of plant-derived antiviral monoclonal antibody (2003) (242)
Roles for glycosylation of cell surface receptors involved in cellular immune recognition. (1999) (242)
Contrasting IgG structures reveal extreme asymmetry and flexibility. (2002) (233)
Genomics Meets Glycomics—The First GWAS Study of Human N-Glycome Identifies HNF1α as a Master Regulator of Plasma Protein Fucosylation (2010) (224)
Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. (2006) (218)
Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. (2010) (214)
Variability, heritability and environmental determinants of human plasma N-glycome. (2009) (212)
Aberrant PSA glycosylation—a sweet predictor of prostate cancer (2013) (204)
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. (2008) (200)
Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. (2010) (192)
Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. (2008) (191)
Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. (1997) (191)
Conformation-Independent Binding of Monoglucosylated Ribonuclease B to Calnexin (1997) (189)
Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. (2010) (189)
Novel glycan biomarkers for the detection of lung cancer. (2011) (185)
Concepts and principles of glycobiology (1993) (184)
An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. (2002) (177)
The Hemopexin and O-Glycosylated Domains Tune Gelatinase B/MMP-9 Bioavailability via Inhibition and Binding to Cargo Receptors* (2006) (174)
The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions. (2015) (173)
Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. (2011) (170)
Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. (2006) (162)
Altered Glycosylation in Tumours Focused to Cancer Diagnosis (2009) (160)
Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. (2010) (160)
The Glycosylation of the Complement Regulatory Protein, Human Erythrocyte CD59* (1997) (158)
Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis (2009) (158)
Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs. (2016) (154)
A comparative study of free oligosaccharides in the milk of domestic animals (2014) (151)
Human Serum IgM Glycosylation (2005) (150)
Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. (2003) (144)
Prion glycoprotein: structure, dynamics, and roles for the sugars. (2001) (141)
Combining Human Computing and Machine Learning to Make Sense of Big (Aerial) Data for Disaster Response (2016) (137)
Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. (2000) (135)
Mannan binding lectin and its interaction with immunoglobulins in health and in disease. (2006) (134)
UniCarb-DB: a database resource for glycomic discovery (2011) (130)
Oligosaccharide sequencing technology (1997) (130)
"Internal residue loss": rearrangements occurring during the fragmentation of carbohydrates derivatized at the reducing terminus. (2002) (128)
Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy (2017) (128)
Molecular mechanism of lipopeptide presentation by CD1a. (2005) (126)
Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophilic interaction chromatography. (2011) (124)
The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. (2008) (124)
Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms. (2011) (122)
The role and importance of glycosylation of acute phase proteins with focus on alpha-1 antitrypsin in acute and chronic inflammatory conditions. (2014) (121)
Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC. (2014) (119)
Glycosylation and the complement system. (2002) (119)
Complement regulation at the molecular level: the structure of decay-accelerating factor. (2004) (118)
Glycosylation of liver acute‐phase proteins in pancreatic cancer and chronic pancreatitis (2010) (117)
Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. (2008) (114)
Genes contributing to prion pathogenesis. (2008) (114)
EUROCarbDB: An open-access platform for glycoinformatics (2010) (113)
Human Follicular Lymphoma Cells Contain Oligomannose Glycans in the Antigen-binding Site of the B-cell Receptor* (2007) (113)
Matrix remodelling enzymes, the protease cascade and glycosylation. (2001) (109)
N- and O-glycosylation analysis of etanercept using liquid chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality. (2014) (108)
Recovery of intact 2-aminobenzamide-labeled O-glycans released from glycoproteins by hydrazinolysis. (2002) (107)
Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody. (2004) (105)
A high‐performance liquid chromatography based strategy for rapid, sensitive sequencing of N‐linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands (2001) (105)
Cell-specific Glycoforms of Sialoadhesin and CD45 Are Counter-receptors for the Cysteine-rich Domain of the Mannose Receptor* (1999) (102)
N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line. (1989) (101)
Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. (2005) (101)
Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2 (2009) (101)
Rapid, sensitive sequencing of oligosaccharides from glycoproteins. (1997) (100)
The Glycosylation of Human Serum IgD and IgE and the Accessibility of Identified Oligomannose Structures for Interaction with Mannan-Binding Lectin1 (2004) (100)
Identification of N-linked carbohydrates from severe acute respiratory syndrome (SARS) spike glycoprotein (2010) (99)
The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator. (1995) (99)
MIRAGE: The minimum information required for a glycomics experiment (2014) (97)
Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. (2007) (97)
Sugar-mediated ligand-receptor interactions in the immune system. (2004) (97)
Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. (1999) (96)
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes (2016) (96)
Automated, high-throughput IgG-antibody glycoprofiling platform. (2013) (95)
Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. (1994) (92)
Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. (2006) (92)
Mutations in HNF1A Result in Marked Alterations of Plasma Glycan Profile (2013) (92)
IgG Glycome in Colorectal Cancer (2016) (90)
Glycan structures of ocular surface mucins in man, rabbit and dog display species differences (2008) (90)
Glycosylation and Fc receptors. (2014) (89)
Genomic Cloning and Expression of Three Murine UDP-galactose: β-N-Acetylglucosamine β1,3-Galactosyltransferase Genes* (1998) (87)
Examination of complex oligosaccharides by matrix‐assisted laser desorption/ionization mass spectrometry on time‐of‐flight and magnetic sector instruments (1994) (87)
Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator. (1989) (85)
Correction: The Mannose Receptor Mediates Dengue Virus Infection of Macrophages (2008) (85)
Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia. (2010) (85)
Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. (1999) (84)
Separation‐based Glycoprofiling Approaches using Fluorescent Labels (2007) (84)
O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. (2000) (83)
Toolboxes for a standardised and systematic study of glycans (2014) (82)
Glycosylation and prion protein. (2002) (80)
Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. (2008) (79)
Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. (2011) (78)
Controlled glycosylation of therapeutic antibodies in plants. (2004) (77)
Estrogens regulate glycosylation of IgG in women and men. (2017) (76)
The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data (2016) (76)
Quantitation of the oligosaccharides of human serum IgG from patients with rheumatoid arthritis: a critical evaluation of different methods. (1998) (75)
Multiplexed analytical glycomics: rapid and confident IgG N-glycan structural elucidation. (2011) (73)
Cells regulate the activities of cytokines by glycosylation (1995) (73)
Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states. (2003) (72)
Galactosemia, a Single Gene Disorder With Epigenetic Consequences (2010) (70)
Exploring the Glycosylation of Serum CA125 (2013) (69)
Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance. (2001) (69)
Complex genetic regulation of protein glycosylation. (2010) (68)
Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. (2007) (68)
Fc gamma receptors: glycobiology and therapeutic prospects (2016) (68)
The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. (2003) (67)
Glycosylation of plasma IgG in colorectal cancer prognosis (2016) (67)
Erythropoietin produced in a human cell line (Dynepo) has significant differences in glycosylation compared with erythropoietins produced in CHO cell lines. (2011) (66)
Identification of Specific Glycoforms of Major Histocompatibility Complex Class I Heavy Chains Suggests That Class I Peptide Loading Is an Adaptation of the Quality Control Pathway Involving Calreticulin and ERp57* (2002) (66)
EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein (2013) (66)
Glycosylation Influences the Lectin Activities of the Macrophage Mannose Receptor* (2005) (66)
Synergizing metabolic flux analysis and nucleotide sugar metabolism to understand the control of glycosylation of recombinant protein in CHO cells (2011) (66)
Glycosylation as a marker for inflammatory arthritis. (2014) (65)
Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species. (2014) (65)
Changes of serum glycans during sepsis and acute pancreatitis. (2007) (65)
Diversification of the IgG molecule by oligosaccharides. (1991) (62)
Glycan characterization of PSA 2-DE subforms from serum and seminal plasma. (2010) (61)
UniCarbKB: Putting the pieces together for glycomics research (2011) (61)
IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia. (2012) (58)
Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions. (2014) (58)
Towards a standardized bioinformatics infrastructure for N- and O-glycomics (2019) (57)
Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. (2006) (57)
Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. (2006) (57)
The minimum information required for a glycomics experiment (MIRAGE) project: sample preparation guidelines for reliable reporting of glycomics datasets. (2016) (56)
GlycoStore: a database of retention properties for glycan analysis (2018) (56)
Dengue Virus Glycosylation: What Do We Know? (2017) (55)
Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab* (2017) (52)
Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. (2008) (51)
Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis. (2013) (51)
Divergent Mechanisms of Interaction of Helicobacter pylori and Campylobacter jejuni with Mucus and Mucins (2013) (51)
5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer (2011) (51)
Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment. (2013) (49)
Major Histocompatibility Complex Class I Molecules Expressed with Monoglucosylated N-Linked Glycans Bind Calreticulin Independently of Their Assembly Status* (2004) (49)
Monitoring endoplasmic reticulum-to-Golgi traffic of a plant calreticulin by protein glycosylation analysis. (2002) (49)
Inactivation of GDP‐fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR‐Cas9 for production of fucose‐free antibodies (2016) (49)
Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d (2010) (49)
Common aberrations from the normal human plasma N-glycan profile. (2010) (49)
Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG. (2008) (48)
Effect of sialic acid content on glycoprotein pI analyzed by two‐dimensional electrophoresis (2010) (48)
Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structure (2004) (47)
2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly-N-acetyl lactosamine extensions. (2011) (47)
O-Glycan Sialylation and the Structure of the Stalk-like Region of the T Cell Co-receptor CD8* (2003) (47)
N-glycan abnormalities in children with galactosemia. (2014) (47)
Sialylation of N-Linked Glycans Influences the Immunomodulatory Effects of IgM on T Cells (2015) (47)
Symbol nomenclature for representing glycan structures: Extension to cover different carbohydrate types (2011) (46)
Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays (2011) (46)
Presence of terminal N-acetylgalactosamineβ1-4N-acetylglucosamine residues on O-linked oligosaccharides from gastric MUC5AC: involvement in Helicobacter pylori colonization? (2012) (45)
An automated robotic platform for rapid profiling oligosaccharide analysis of monoclonal antibodies directly from cell culture. (2013) (44)
Targeted identification of a unique glycan epitope of Schistosoma mansoni egg antigens using a diagnostic antibody. (2007) (44)
The sweet spot for biologics: recent advances in characterization of biotherapeutic glycoproteins (2018) (44)
Plasma N-glycans in colorectal cancer risk (2018) (44)
Strategies for the profiling, characterisation and detailed structural analysis of N-linked oligosaccharides (2013) (43)
Liver proteins as sensor of human malignancies and inflammation (2010) (43)
Automated, high-throughput serum glycoprofiling platform. (2015) (42)
Remnant epitopes, autoimmunity and glycosylation. (2006) (42)
The second golden age of glycomics: from functional glycomics to clinical applications. (2009) (41)
New technologies and their impact on 'omics' research. (2013) (41)
Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells. (1999) (41)
Databases and Associated Tools for Glycomics and Glycoproteomics. (2017) (41)
IgG Glycosylation Changes and MBL2 Polymorphisms: Associations with Markers of Systemic Inflammation and Joint Destruction in Rheumatoid Arthritis (2012) (40)
Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin. (2015) (40)
Ultrahigh throughput, ultrafiltration-based n-glycomics platform for ultraperformance liquid chromatography (ULTRA(3)). (2015) (39)
Ion mobility separation of deprotonated oligosaccharide isomers - evidence for gas-phase charge migration. (2016) (39)
Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? (2006) (39)
Biosimilarity Versus Manufacturing Change: Two Distinct Concepts (2015) (39)
Structural characterization of the N-glycan moiety and site of glycosylation in vitellogenin from the decapod crustacean Cherax quadricarinatus. (2004) (39)
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer (2018) (39)
The Activation of Type 1 and Type 2 Plasminogen by Type I and Type II Tissue Plasminogen Activator (*) (1995) (39)
Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design. (2003) (38)
Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients. (2010) (38)
Direct deprotected glycosyl-asparagine ligation. (2006) (38)
Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis (2016) (38)
NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods* (2019) (38)
GlycopeptideGraphMS: Improved Glycopeptide Detection and Identification by Exploiting Graph Theoretical Patterns in Mass and Retention Time. (2019) (38)
Increase in Sialylation and Branching in the Mouse Serum N-glycome Correlates with Inflammation and Ovarian Tumour Progression (2013) (38)
A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD. (1994) (37)
Structural determination of the N-glycans of a lepidopteran arylphorin reveals the presence of a monoglucosylated oligosaccharide in the storage protein. (2003) (37)
Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry. (2010) (37)
Fragmentation of negative ions from N-linked carbohydrates, part 4. Fragmentation of complex glycans lacking substitution on the 6-antenna. (2010) (36)
High throughput plasma N-glycome profiling using multiplexed labelling and UPLC with fluorescence detection. (2011) (36)
Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1. (2015) (36)
Mass Spectrometric Quantification of N-Linked Glycans by Reference to Exogenous Standards. (2016) (36)
Fragmentation of negative ions from N-linked carbohydrates. Part 5: Anionic N-linked glycans (2011) (36)
Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines. (2016) (35)
Association of medication with the human plasma N-glycome. (2012) (35)
Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants. (2010) (35)
A variant human IgG1-Fc mediates improved ADCC. (2011) (35)
Hybrid and complex glycans are linked to the conserved N-glycosylation site of the third eight-cysteine domain of LTBP-1 in insect cells. (2000) (35)
Separation and analysis of the glycoform populations of ribonuclease B using capillary electrophoresis (1992) (34)
Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling (2018) (33)
Acute phase glycoproteins: bystanders or participants in carcinogenesis? (2012) (33)
Influence of Baculovirus‐Host Cell Interactions on Complex N‐Linked Glycosylation of a Recombinant Human Protein (2000) (33)
Comprehensive Profiling of Glycosphingolipid Glycans Using a Novel Broad Specificity Endoglycoceramidase in a High-Throughput Workflow. (2016) (33)
Structural analysis of the CD5 antigen--expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1. (1998) (32)
Mutant analysis reveals an alternative pathway for N-linked glycosylation in Drosophila melanogaster. (1998) (32)
The minimum information required for a glycomics experiment (MIRAGE) project: LC guidelines. (2019) (32)
O-Linked Glycosylation in Focus (2000) (32)
Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation (2014) (32)
Glycan characterization of the NIST RM monoclonal antibody using a total analytical solution: From sample preparation to data analysis (2017) (32)
Serum N‐glycan analysis in breast cancer patients – Relation to tumour biology and clinical outcome (2016) (31)
High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes* (2018) (31)
Identification of O-glycan Structures from Chicken Intestinal Mucins Provides Insight into Campylobactor jejuni Pathogenicity* (2015) (30)
Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals. (2006) (30)
Determining the Structure of Oligosaccharides N‐ and O‐Linked to Glycoproteins (2000) (30)
The identification and characterization of xenoantigenic nonhuman carbohydrate sequences in membrane proteins from porcine kidney (2006) (30)
Orthogonal Technologies for NISTmAb N-Glycan Structure Elucidation and Quantitation (2015) (29)
Chapter 3:Changes in Serum N-Glycosylation Profiles: Functional Significance and Potential for Diagnostics (2011) (29)
Antipsychotic treatment of acute paranoid schizophrenia patients with olanzapine results in altered glycosylation of serum glycoproteins. (2012) (29)
Quantitative profiling of glycans and glycopeptides: an informatics' perspective. (2016) (29)
Identification of N-glycans displaying mannose-6-phosphate and their site of attachment on therapeutic enzymes for lysosomal storage disorder treatment. (2011) (29)
GlycoDigest: a tool for the targeted use of exoglycosidase digestions in glycan structure determination (2014) (28)
High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes. (2019) (28)
Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides. (2006) (28)
Glycosylation Repurposes Alpha‐1 Antitrypsin for Resolution of Community‐acquired Pneumonia (2017) (28)
N-linked glycan structures of the human Fcγ receptors produced in NS0 cells. (2013) (28)
Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems—The taliglucerase alfa story (2017) (28)
Clinical, neuroradiological, and biochemical features of SLC35A2‐CDG patients (2019) (27)
Cytokine and protease glycosylation as a regulatory mechanism in inflammation and autoimmunity. (1998) (27)
Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer (2016) (27)
Oligosaccharides of recombinant mouse gelatinase B variants. (1998) (26)
Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation (2006) (26)
Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria. (2006) (26)
Structural characterisation of the N-glycan moiety of the barnacle settlement-inducing protein complex (SIPC) (2012) (26)
EndoE from Enterococcus faecalis Hydrolyzes the Glycans of the Biofilm Inhibiting Protein Lactoferrin and Mediates Growth (2014) (26)
Oligosaccharides modulate the apoptotic activity of glycodelin. (2006) (25)
Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. (2012) (25)
High-throughput quantitative N-glycan analysis of glycoproteins. (2012) (25)
Effects of temporary low-dose galactose supplements in children aged 5–12 y with classical galactosemia: a pilot study (2015) (25)
Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3. (2006) (25)
Mutations in HNF 1 A Result in Marked Alterations of Plasma Glycan Pro fi le (2013) (25)
Increased outer arm and core fucose residues on the N-glycans of mutated alpha-1 antitrypsin protein from alpha-1 antitrypsin deficient individuals. (2014) (24)
Identification and removal of O-linked and non-covalently linked sugars from recombinant protein produced using Pichia pastoris. (2004) (24)
Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis (2012) (24)
GlycoExtractor: a web-based interface for high throughput processing of HPLC-glycan data. (2010) (24)
Glycoproteins: rapid sequencing technology for N-linked and GPI anchor glycans. (1999) (24)
Collision Cross Sections and Ion Mobility Separation of Fragment Ions from Complex N-Glycans (2018) (23)
Monosialylated biantennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk. (2008) (23)
The impact of cell adaptation to serum-free conditions on the glycosylation profile of a monoclonal antibody produced by Chinese hamster ovary cells. (2013) (23)
The identification of abnormal glycoforms of serum transferrin in carbohydrate deficient glycoprotein syndrome type i by capillary zone electrophoresis (1996) (23)
Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids (2015) (23)
N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency. (2015) (23)
The carbohydrate moiety of serum IgM from Atlantic cod (Gadus morhua L.). (2002) (23)
Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles. (2001) (23)
GlycoBase and autoGU: resources for interpreting HPLC-glycan data. (2015) (22)
Comparison of the N-linked glycans from soluble and GPI-anchored CD59 expressed in CHO cells. (2002) (22)
NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods. (2020) (21)
Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic Retinopathy (2010) (21)
Plant N-glycan profiling of minute amounts of material. (2008) (21)
Human immunoglobulin glycosylation and the lectin pathway of complement activation. (2005) (21)
N‐glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome (2018) (21)
Serum N‐glycome alterations in breast cancer during multimodal treatment and follow‐up (2017) (21)
Methodologies for screening of bacteria-carbohydrate interactions: anti-adhesive milk oligosaccharides as a case study. (2012) (21)
Structural characterization of N-linked oligosaccharides on monoclonal antibody Nimotuzumab through process development. (2012) (20)
Glycomics meets lipidomics--associations of N-glycans with classical lipids, glycerophospholipids, and sphingolipids in three European populations. (2011) (20)
Determining the Structure of Glycan Moieties by Mass Spectrometry (2000) (20)
The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody (2013) (20)
The glycan processing and site occupancy of recombinant Thy-1 is markedly affected by the presence of a glycosylphosphatidylinositol anchor. (1999) (20)
N-glycosylation pattern of E2 glycoprotein from classical swine fever virus. (2009) (19)
High-Throughput Analysis of the Plasma N-Glycome by UHPLC. (2017) (19)
Databases and tools in glycobiology. (2012) (19)
Comparison of analytical methods for profiling N- and O-linked glycans from cultured cell lines (2016) (19)
In vitro generation of polysialylated cervical mucins by bacterial polysialyltransferases to counteract cytotoxicity of extracellular histones (2017) (19)
Utility of Ion-Mobility Spectrometry for Deducing Branching of Multiply Charged Glycans and Glycopeptides in a High-Throughput Positive ion LC-FLR-IMS-MS Workflow. (2020) (19)
Hypoxia Alters Epigenetic and N-Glycosylation Profiles of Ovarian and Breast Cancer Cell Lines in-vitro (2020) (18)
The conformational properties of the Glc3Man unit suggest conformational biasing within the chaperone-assisted glycoprotein folding pathway. (2009) (18)
Protein structure controls the processing of the N-linked oligosaccharides and glycosylphosphatidylinositol glycans of variant surface glycoproteins expressed in bloodstream form Trypanosoma brucei. (2000) (18)
Comprehensive N-Glycan Profiling of Avian Immunoglobulin Y (2016) (18)
Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease (2019) (18)
Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity (2019) (17)
Inhibition of α-Glucosidases I and II Increases the Cell Surface Expression of Functional Class A Macrophage Scavenger Receptor (SR-A) by Extending Its Half-life* (2004) (17)
HPLC Strategies for Profiling and Sequencing Oligosaccharides (1997) (16)
At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody (2016) (16)
High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis (2017) (16)
The presence of outer arm fucose residues on the N-glycans of tissue inhibitor of metalloproteinases-1 reduces its activity. (2013) (15)
IgG Fc glycosylation as an axis of humoral immunity in childhood. (2020) (15)
Region-specific characterization of N-glycans in striatum and substantia nigra of an adult rodent brain. (2020) (15)
Advances in analytical methodologies to guide bioprocess engineering for bio-therapeutics. (2017) (15)
Sialic acid mediated mechanical activation of β2 adrenergic receptors by bacterial pili (2019) (15)
Groove-type Recognition of Chlamydiaceae-specific Lipopolysaccharide Antigen by a Family of Antibodies Possessing an Unusual Variable Heavy Chain N-Linked Glycan* (2014) (15)
EndoS 2 is a unique and conserved enzyme of serotype M 49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α 1-acid glycoprotein (2016) (14)
The goat mammary glandular epithelial (GMGE) cell line promotes polyfucosylation and N,N'-diacetyllactosediaminylation of N-glycans linked to recombinant human erythropoietin. (2007) (13)
A novel broad specificity fucosidase capable of core α1-6 fucose release from N-glycans labeled with urea-linked fluorescent dyes (2018) (13)
Validation of an automated ultraperformance liquid chromatography IgG N-glycan analytical method applicable to classical galactosaemia (2018) (13)
Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing (2007) (13)
Glycosylation and the Complement System (2002) (13)
Glycosylation and the immune system. (1999) (13)
GlycanAnalyzer: software for automated interpretation of N-glycan profiles after exoglycosidase digestions (2018) (13)
Combining Glucose Units, m/z and Collision Cross Section values: Multi-attribute data for increased accuracy in automated glycosphingolipid glycan identifications and its application in Triple Negative Breast Cancer. (2019) (12)
Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis. (2005) (12)
High-throughput glycome analysis is set to join high-throughput genomics. (2009) (12)
Glycosylation: disease targets and therapy. (2005) (12)
High-throughput screening of glycan-binding proteins using miniature pig kidney N-glycan-immobilized beads. (2008) (12)
Glycosylation of Therapeutic IgGs (2009) (12)
Detailed N-glycan analysis of mannose receptor purified from murine spleen indicates tissue specific sialylation. (2009) (12)
Artefacts formed by addition of urea to N-linked glycans released with peptide-N-glycosidase F for analysis by mass spectrometry. (2004) (11)
Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling (2020) (11)
A carbohydrate-binding affinity ligand for the specific enrichment of glycoproteins. (2016) (11)
Structural Elucidation of the N- andO-Glycans of Human Apolipoprotein(a) (2001) (11)
A strategy for anti-viral intervention: the use of alpha-glucosidase inhibitors to prevent chaperone-mediated folding of viral envelope glycoproteins. (1997) (11)
Discovering new clinical markers in the field of glycomics. (2011) (11)
Identification of by-products formed during the release of N-glycans with protein N-glycosidase F in the presence of dithiothreitol. (2010) (11)
Characterizing Protein Glycosylation through On-Chip Glycan Modification and Probing. (2016) (11)
Shotgun Glycomics Identifies Tumor-Associated Glycan Ligands Bound by an Ovarian Carcinoma-Specific Monoclonal Antibody (2017) (11)
Aminoquinoline Fluorescent Labels Obstruct Efficient Removal of N-Glycan Core α(1-6) Fucose by Bovine Kidney α-l-Fucosidase (BKF). (2017) (10)
The O-Glycome of Human Nigrostriatal Tissue and Its Alteration in Parkinson’s Disease (2021) (10)
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells (2021) (10)
Identification of high-mannose and multiantennary complex-type N-linked glycans containing α-galactose epitopes from Nurse shark IgM heavy chain (2009) (10)
High-throughput glycoanalytical technology for systems glycobiology. (2010) (10)
A Robust and Versatile Automated Glycoanalytical Technology for Serum Antibodies and Acute Phase Proteins: Ovarian Cancer Case Study* (2019) (9)
Analysing mucin degradation. (2012) (9)
Serum N-Glycome Characterization in Patients with Resectable Periampullary Adenocarcinoma. (2015) (9)
Bioinformatics applications to aid high-throughput glycan profiling☆ (2017) (9)
Toward a carbohydrate-based HIV-1 vaccine (2006) (9)
The N-glycosylation of classical swine fever virus E2 glycoprotein extracellular domain expressed in the milk of goat. (2010) (9)
Lectin-carbohydrate interactions in disease. T-cell recognition of IgA and IgD; mannose binding protein recognition of IgG0. (1995) (9)
Applications of electrospray mass spectrometry to studies on the structural properties of ribonuclease A and ribonuclease B (1993) (9)
Crystal structure of the TCR co-receptor CD8alphaalpha in complex with monoclonal antibody YTS 105.18 Fab fragment at 2.88 A resolution. (2006) (9)
Genome-wide association study identifies FUT8 and ESR2 as co-regulators of a bi-antennary N-linked glycan A2 (GlcNAc~2~Man~3~GlcNAc~2~) in human plasma proteins (2009) (8)
Lectin-Carbohydrate Interactions in Disease (1995) (8)
GlycoProfileAssigner: automated structural assignment with error estimation for glycan LC data (2015) (8)
Expression, Purification, and Biochemical Characterization of Human Afamin. (2018) (8)
IgG N-Glycosylation Galactose Incorporation Ratios for the Monitoring of Classical Galactosaemia. (2015) (8)
Glycosylation and the function of the T cell co-receptor CD8. (2005) (8)
Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome. (2010) (8)
Glycoproteomics in Health and Disease (2010) (7)
Glycomics and Glycoproteomics (2017) (7)
The glycosylation of the complement regulatory protein, human erythrocyte CD59. (1997) (7)
LC/MS-based Intact IgG and Released Glycan Analysis for Bioprocessing Applications. (2018) (7)
Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy (2020) (6)
Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes: Erratum (2018) (6)
Greedy feature selection for glycan chromatography data with the generalized Dirichlet distribution (2013) (6)
Lectins as Indicators of Disease-Associated Glycoforms (1993) (6)
Therapeutic Proteins: Facing the Challenges of Glycobiology (2014) (5)
Interaction of Mannan Binding Lectin with α2 Macroglobulin via Exposed Oligomannose Glycans (2006) (5)
Translational glycobiology: from bench to bedside (2019) (5)
Aminoquinolines as fluorescent labels for hydrophilic interaction liquid chromatography of oligosaccharides (2012) (5)
Structural glycobiology in medicine: Carbohydrates and glycoconjugates (2006) (5)
Disease related glycosylation changes and biomarker discovery: challenges and possibilities in an emerging field. Editorial. (2008) (5)
Erratum: Protein structure controls the processing of the N-linked oligosaccharides and glycosylphosphatidylinositol glycans of variant surface glycoproteins expressed in bloodstream form Trypanosoma brucei (Glycobiology vol. 10 (243-249)) (2000) (5)
Pregnancy-Associated Changes of IgG and Serum N-Glycosylation in Camel (Camelus dromedarius). (2016) (5)
A Robust and Versatile Automated Glycoanalytical Technology for Serum Antibodies and Acute Phase Proteins: Ovarian Cancer Case Study. (2019) (5)
Exploiting the Di-Sialyl Galactose Activity of α2,6 Sialyltransferase from Photobacterium Damselae to Generate a Highly Sialylated Recombinant Alpha-1-Antitrypsin. (2020) (4)
Determining the Structure of Oligosaccharides N‐ and O‐Linked to Glycoproteins (2000) (4)
Glycosylation influences the ligand binding activities of mannose receptor. (2005) (4)
Antibody recognition of a carbohydrate epitope: a template for HIV vaccine design. (2005) (4)
e-workflow for recording of glycomic mass spectrometric data in compliance with reporting guidelines (2018) (4)
Roles for glycosylation in the anti-inflammatory molecule CD59. (1997) (4)
N-Linked glycosylation profiles of therapeutic induced senescent (TIS) triple negative breast cancer cells (TNBC) and their extracellular vesicle (EV) progeny. (2020) (4)
Clustering and curation of electropherograms: an efficient method for analyzing large cohorts of capillary electrophoresis glycomic profiles for bioprocessing operations (2020) (4)
The First Genome Wide Association Study of Human Glycome Identifies HNF1 alpha as a Master Regulator of Plasma Protein Fucosylation (2010) (4)
Routier, F. H. et al. Quantitation of the oligosaccharides of human serum IgG from patients with rheumatoid arthritis: a critical evaluation of different methods. J. Immunol. Methods 213, 113-130 (1998) (3)
Commentary on paper: 5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene (Chachadi et al.). (2012) (3)
N-glycan profiling of bovine follicular fluid at key dominant follicle developmental stages. (2014) (3)
A HPLC-based glycoanalytical protocol allows the use of natural O-glycans derived from glycoproteins as substrates for glycosidase discovery from microbial culture (2013) (3)
Importance and Monitoring of Therapeutic Immunoglobulin G Glycosylation. (2021) (3)
Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation (2022) (3)
Application of Compositional Models for Glycan HILIC Data (2011) (3)
Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy (2017) (3)
Exploiting the Disialyl Galactose Activity of 2,6- Sialyltransferase from Photobacterium damselae To Generate a Highly Sialylated Recombinant -1-Antitrypsin (2019) (2)
Contributions from Spirituality: Simplicity— Complexity— Simplicity (2008) (2)
3.41 – Protein Glycosylation (2011) (2)
Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology (2012) (2)
Distinct Glycosylation Responses to Spinal Cord Injury in Regenerative and Nonregenerative Models (2022) (2)
High-Throughput HPLC-based N-Glycan Analysis of Human Plasma Proteins Identifies Potential Biomarkers for Maturity Onset Diabetes of the Young (MODY) (2011) (1)
Lectins and glycoimmunology (PP-027) (2010) (1)
Biochemical and Glycomic effects of diet relaxation in Classical Galactosaemia (2010) (1)
Differential glycosylation of gelatinase B from neutrophils and breast cancer cells. (2005) (1)
Analysis of N‐ and O‐linked glycans of glycoproteins (2005) (1)
212 Skin Glycomics - Characterization of the N-glycome in the Stratum Corneum of Aged and Dry skin (2019) (1)
Holistic approaches to glycobiology (2001) (1)
Greedy feature selection for glycan chromatography data with the generalized Dirichlet distribution (2013) (1)
Erratum: At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody (2017) (1)
Supporting Information for Practical Review DOI 10.1002/pmic.200700640 (2007) (1)
Toolboxes for a standardised and systematic study of glycans (2014) (1)
ROLES FOR GLYCOSYLATION IN RECEPTOR- LIGAND INTERACTIONS IN THE IMMUNE SYSTEM (2005) (1)
Linking glycomics repositories with data capture (2012) (1)
The minimum information required for a glycomics experiment (MIRAGE): reporting guidelines for capillary electrophoresis. (2022) (1)
Glycoproteomics: High-Throughput Sequencing of Oligosaccharide Modifications to Proteins (2001) (1)
Correction for Muindi et al., Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphinogolipids presented by CD1d (2010) (1)
Direct Deprotected Glycosyl—Asparagine Ligation. (2006) (1)
Glycoinformatics Tools for Comprehensive Characterization of Glycans Enzymatically Released from Proteins. (2022) (1)
Informatics and Analytical Tools for Glycan Analysis and the Development of Biotherapeutics (2015) (1)
Immunogenicity of calreticulin-bound murine leukemia virus glycoprotein gp90. (2005) (0)
5‐AZA‐2'‐deoxycytidine induced demethylation influences N‐glycosylation of secreted glycoproteins in ovarian cancer (608.1) (2014) (0)
CHOmpact: a reduced metabolic model of Chinese hamster ovary cells with enhanced interpretability (2021) (0)
A specific glycoform of MHC1 is required for the formation of the multimolecular complex involved in the assembly of the MHC1:peptide complexes (2002) (0)
GlycoStore: A Platform for H/UPLC and Capillary Electrophoresis Glycan Data. (2022) (0)
Unliganded 1 crystal structure of S25-26 Fab (2014) (0)
Abstract 2423: Hypoxia regulates tumor cell invasiveness through altered glycosylation (2018) (0)
Glycoinformatic Platforms for Data Interpretation: An HPLC Perspective (2010) (0)
Comparison of analytical methods for profiling N- and O-linked glycans from cultured cell lines (2015) (0)
In Vitro Sialylation of Recombinant Alpha-1-Antitrypsin using α2,6 Sialyltransferase from Photobacterium Damselae Produces Di-sialyl Galactose Motifs in N-Glycans (2019) (0)
Meeting report on 14th Jenner Glycobiology and Medicine Symposium: glycobiology in immunology, medicine, and clinical practice (2022) (0)
Developing a Scientific Library for UPLC/FLR/MS Analysis of Released N-glycans Labeled with a Novel Tagging Reagent (2015) (0)
Human apolipoprotein B-100 oligosaccharide structure is not altered in familial hypercholesterolaemia or non insulin dependent diabetes (2001) (0)
GlycoScience Ireland Initiative (2008) (0)
Abstract 5544: New technologies to probe the systems glycobiology of cancer (2017) (0)
Complex carbohydrates as a predictive marker in metastatic colorectal cancer (mCRC) cancer patients treated with a vascular endothelial growth factor (VEGF) inhibitor and chemotherapy. (2017) (0)
Glycoconjugates — Composition, structure and function (1993) (0)
Keratan sulphate in endometrium and placenta (2002) (0)
Decay accelerating factor (CD55): the structure of an intact human complement regulator. (2004) (0)
“Holistic approaches to glycobiology” (2001) (0)
Micro-Heterogeneity of Antibody Molecules. (2021) (0)
Determining the Structure of Glycan Moieties by Mass Spectrometry (2000) (0)
CD8alpha-alpha in complex with YTS 105.18 Fab (2006) (0)
Traitement à base de liposomes des infections virales (2007) (0)
1150 Altered Glycosylation of Serum Glycoproteins as Tumour Biomarkers – the Case of Prostate-specific Antigen in Prostate Cancer and the Case of Acute-phase Proteins in Pancreatic Adenocarcinoma (2012) (0)
Dedicated resources for MPT identification (2011) (0)
Crystal Structure of Fab 2G12 bound to Man9GlcNAc2 (2003) (0)
Abstract 97: Increased Plasma Level of ApoCIII-rich Electronegative HDL May Contribute to Cognitive Impairment in Alzheimer’s Disease (2017) (0)
Glycan Analyzer: Software to Annotate Glycan Structures from Exoglycosidase Experiments (2018) (0)
GlycanAnalyzer: software for automated interpretation of N-glycan profiles after exoglycosidase digestions (2019) (0)
New technology for analysis of sugar chain structure.2.Full-automatic glycoprotein sugar chain analysis system. (1994) (0)
Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy (2020) (0)
LOCI ASSOCIATED WITH N-GLYCOSYLATION OF HUMAN IGG SHOW PLEIOTROPY WITH AUTOIMMUNE DISEASES AND HAEMATOLOGICAL CANCERS (2013) (0)
Crystal structure of S25-26 in complex with Kdo(2.8)Kdo(2.4)Kdo trisaccharide (2014) (0)
Crystal Structure of Fab 2G12 bound to Man1->2Man (2003) (0)
Glycosylation of C1 Inhibitor (2000) (0)
Mannan-Binding Lectin Oligomannose Structures for Interaction with IgE and the Accessibility of Identified The Glycosylation of Human Serum IgD and (2004) (0)
FAB 2G12 unliganded (2003) (0)
Systems Glyciobiology: from Genome to Glycome (2011) (0)
Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations (2011) (0)
Supplementary Material 11 (2014) (0)
Glycobiology – discovery, diagnosticsand drugs (2007) (0)
P–340 Novel non-invasive diagnostic options for endometriosis - based on glycome analysis (2021) (0)
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells (2021) (0)
Exploring Functions for Glycosylation in Host Defence using Novel Oligosaccharide Sequencing Technology (2000) (0)
Quantifying the partition of demoresources between cellular and recombinant protein glycosylation in GS-CHO cells (2018) (0)
Strategies for the profiling, characterisation and detailed structural analysis of N-linked oligosaccharides (2012) (0)
A novel broad specificity fucosidase capable of core α1-6 fucose release from N-glycans labeled with urea-linked fluorescent dyes (2018) (0)
1,3-Galactosyltransferase Genes β -Acetylglucosamine N - β (2014) (0)
Arthritis Markers of Systemic Inflammation and Joint Destruction in Rheumatoid Polymorphisms : Associations with MBL 2 IgG Glycosylation Changes and (2012) (0)
Glycosylation Studies of Monoclonal Immunoglobulin Deposition Disorders (2004) (0)
Integrated strategy for identifying and screening potential cancer biomarkers (2008) (0)
Detailed analysis of serum glycans in sepsis and acute pancreatitis (2006) (0)
A HPLC-based glycoanalytical protocol allows the use of natural O-glycans derived from glycoproteins as substrates for glycosidase discovery from microbial culture (2013) (0)
High-throughput Workflow for Glycan Profiling and Characterisation (2014) (0)
Plasma N-glycans in colorectal cancer risk (2018) (0)
N-glycans are stratum corneum biomarkers of aging skin. (2022) (0)
Editorial (2009) (0)
Shotgun Glycomics Identifies Tumor-Associated Glycan Ligands Bound by an Ovarian Carcinoma-Specific Monoclonal Antibody (2017) (0)
Biosimilarity Versus Manufacturing Change: Two Distinct Concepts (2015) (0)

This paper list is powered by the following services:

Other Resources About Pauline Rudd

en.wikipedia.org
apc.ucc.ie

What Schools Are Affiliated With Pauline Rudd?

Pauline Rudd is affiliated with the following schools:

National University of Ireland
University of Oxford